BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

268 related articles for article (PubMed ID: 28505405)

  • 1. Structural Basis for Xenosiderophore Utilization by the Human Pathogen Staphylococcus aureus.
    Endicott NP; Lee E; Wencewicz TA
    ACS Infect Dis; 2017 Jul; 3(7):542-553. PubMed ID: 28505405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Structural and functional characterization of the Staphylococcus aureus virulence factor and vaccine candidate FhuD2.
    Mariotti P; Malito E; Biancucci M; Lo Surdo P; Mishra RP; Nardi-Dei V; Savino S; Nissum M; Spraggon G; Grandi G; Bagnoli F; Bottomley MJ
    Biochem J; 2013 Feb; 449(3):683-93. PubMed ID: 23113737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. FhuD1, a ferric hydroxamate-binding lipoprotein in Staphylococcus aureus: a case of gene duplication and lateral transfer.
    Sebulsky MT; Speziali CD; Shilton BH; Edgell DR; Heinrichs DE
    J Biol Chem; 2004 Dec; 279(51):53152-9. PubMed ID: 15475351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Crystal and solution structure analysis of FhuD2 from Staphylococcus aureus in multiple unliganded conformations and bound to ferrioxamine-B.
    Podkowa KJ; Briere LA; Heinrichs DE; Shilton BH
    Biochemistry; 2014 Apr; 53(12):2017-31. PubMed ID: 24606332
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Immobilized FhuD2 Siderophore-Binding Protein Enables Purification of Salmycin Sideromycins from Streptomyces violaceus DSM 8286.
    Rivera GSM; Beamish CR; Wencewicz TA
    ACS Infect Dis; 2018 May; 4(5):845-859. PubMed ID: 29460625
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification and characterization of fhuD1 and fhuD2, two genes involved in iron-hydroxamate uptake in Staphylococcus aureus.
    Sebulsky MT; Heinrichs DE
    J Bacteriol; 2001 Sep; 183(17):4994-5000. PubMed ID: 11489851
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemical Synthesis of Staphyloferrin B Affords Insight into the Molecular Structure, Iron Chelation, and Biological Activity of a Polycarboxylate Siderophore Deployed by the Human Pathogen Staphylococcus aureus.
    Madsen JL; Johnstone TC; Nolan EM
    J Am Chem Soc; 2015 Jul; 137(28):9117-27. PubMed ID: 26030732
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Trihydroxamate siderophore-fluoroquinolone conjugates are selective sideromycin antibiotics that target Staphylococcus aureus.
    Wencewicz TA; Long TE; Möllmann U; Miller MJ
    Bioconjug Chem; 2013 Mar; 24(3):473-86. PubMed ID: 23350642
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Requirement of Staphylococcus aureus ATP-binding cassette-ATPase FhuC for iron-restricted growth and evidence that it functions with more than one iron transporter.
    Speziali CD; Dale SE; Henderson JA; Vinés ED; Heinrichs DE
    J Bacteriol; 2006 Mar; 188(6):2048-55. PubMed ID: 16513734
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The role of FhuD2 in iron(III)-hydroxamate transport in Staphylococcus aureus. Demonstration that FhuD2 binds iron(III)-hydroxamates but with minimal conformational change and implication of mutations on transport.
    Sebulsky MT; Shilton BH; Speziali CD; Heinrichs DE
    J Biol Chem; 2003 Dec; 278(50):49890-900. PubMed ID: 14514690
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hmuUV genes of Sinorhizobium meliloti 2011 encode the permease and ATPase components of an ABC transport system for the utilization of both haem and the hydroxamate siderophores, ferrichrome and ferrioxamine B.
    Cuív PO; Keogh D; Clarke P; O'Connell M
    Mol Microbiol; 2008 Dec; 70(5):1261-73. PubMed ID: 18990190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Staphylococcus aureus heme and siderophore-iron acquisition pathways.
    Conroy BS; Grigg JC; Kolesnikov M; Morales LD; Murphy MEP
    Biometals; 2019 Jun; 32(3):409-424. PubMed ID: 30911924
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nocardamine-Dependent Iron Uptake in
    Normant V; Josts I; Kuhn L; Perraud Q; Fritsch S; Hammann P; Mislin GLA; Tidow H; Schalk IJ
    ACS Chem Biol; 2020 Oct; 15(10):2741-2751. PubMed ID: 32902248
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Direct evidence of iron uptake by the Gram-positive siderophore-shuttle mechanism without iron reduction.
    Fukushima T; Allred BE; Raymond KN
    ACS Chem Biol; 2014 Sep; 9(9):2092-100. PubMed ID: 25007174
    [TBL] [Abstract][Full Text] [Related]  

  • 15. X-ray crystallographic structures of the Escherichia coli periplasmic protein FhuD bound to hydroxamate-type siderophores and the antibiotic albomycin.
    Clarke TE; Braun V; Winkelmann G; Tari LW; Vogel HJ
    J Biol Chem; 2002 Apr; 277(16):13966-72. PubMed ID: 11805094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gram-positive siderophore-shuttle with iron-exchange from Fe-siderophore to apo-siderophore by Bacillus cereus YxeB.
    Fukushima T; Allred BE; Sia AK; Nichiporuk R; Andersen UN; Raymond KN
    Proc Natl Acad Sci U S A; 2013 Aug; 110(34):13821-6. PubMed ID: 23924612
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Deferoxamine mesylate enhances virulence of community-associated methicillin resistant Staphylococcus aureus.
    Arifin AJ; Hannauer M; Welch I; Heinrichs DE
    Microbes Infect; 2014 Nov; 16(11):967-72. PubMed ID: 25251026
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heme-Dependent Siderophore Utilization Promotes Iron-Restricted Growth of the Staphylococcus aureus
    Batko IZ; Flannagan RS; Guariglia-Oropeza V; Sheldon JR; Heinrichs DE
    J Bacteriol; 2021 Nov; 203(24):e0045821. PubMed ID: 34606375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Growth of desferrioxamine-deficient Streptomyces mutants through xenosiderophore piracy of airborne fungal contaminations.
    Arias AA; Lambert S; Martinet L; Adam D; Tenconi E; Hayette MP; Ongena M; Rigali S
    FEMS Microbiol Ecol; 2015 Jul; 91(7):. PubMed ID: 26183915
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of genes, desR and desA, required for utilization of desferrioxamine B as a xenosiderophore in Vibrio furnissii.
    Tanabe T; Funahashi T; Miyamoto K; Tsujibo H; Yamamoto S
    Biol Pharm Bull; 2011; 34(4):570-4. PubMed ID: 21467648
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.